Cantor Fitzgerald Maintains Neutral on Amgen, Raises Price Target to $440

Benzinga · 2d ago
Cantor Fitzgerald analyst Carter Gould maintains Amgen (NASDAQ:AMGN) with a Neutral and raises the price target from $400 to $440.